Increased lithium levels in water could increase the risk of autism.

Published Date: 05 Apr 2023

A new study led by a UCLA Health researcher found that pregnant women had a slightly increased risk of having children with autism spectrum disorder if the household tap water had higher lithium levels.

Read Full News

Latest News

What is Causing This MS Patient's Unusual Symptoms?

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

This Unusual Syndrome of the Face Could Be an Early Sign of AML

Case started with severe pain and numbness

New Autism Committee Chair Founded a Leucovorin Telehealth Company

Drug has been promoted as a treatment for autism

Possible Drug-Drug Interactions Flagged for Older Americans

— Many are on 5+ prescription drugs or dietary supplements

A Dementia Vaccine? Most Americans Say Yes

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Years of Progressing Facial Numbness and Deteriorating Vision Drives Diagnosis

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

Todays Updates

ASTRO: American Society for Radiation Oncology

Todays Updates

ASTRO: American Society for Radiation Oncology

Latest News

Gait problems, twitching, and "strange sensations" atypical of multiple sclerosis

Case started with severe pain and numbness

Drug has been promoted as a treatment for autism

— Many are on 5+ prescription drugs or dietary supplements

— Nearly three-fourths of people 50 or older said they'd get vaccinated if they were at high risk

Suspect perineural recurrence of cutaneous squamous cell carcinoma, experts urge

News All Time

More NFL Players Have CTE Than Previously Thought, Study Suggests

At least 1 in 4 pro players who died from 2016 to 2021 had the progressive brain disorder

Federal Committee Looks Backward as Autism Science Moves Forward

In its second meeting, federal autism committee advances plan that may stymie promising research

New Migraine Prevention Guidance Highlights CGRP Drugs, Broad Eligibility

Guidelines from AAN and AHS get first update since 2012

Will Patient Deaths Derail the CAR-T Train in Autoimmune Disease?

Novartis, BMS reportedly halt trials; first serious blow to burgeoning field

Alzheimer's Genetic Risk; Underreported Dementia; Exercise or Nap After Sleep Loss?

News and commentary from the world of neurology and neuroscience

Study: Chronic Pain May Really Be 'All in Your Head'

Protein from skull bone marrow appears to play a key role

Autism-Vaccine Researcher Says He Stole $1M in CDC Grant Funds

Extradited Danish physician admits guilt in operating wire fraud scheme

Is Paxlovid Any Better Than Placebo for Long COVID?

In three major symptom phenotypes, randomized trial finds no benefit

1,081 Injuries Tied to Device; Military's COVID Shot Probe; Teen Vax Coverage Slides

Health news and commentary gathered by MedPage Today staff

Rare Brain Disorder Gets Its First FDA Drug Approval

Zilganersen targets protein buildup that drives Alexander disease

Parkinson's Risk and Carbon Monoxide: What a New Study Found

Analysis offers surprising twist to the smoking-Parkinson's puzzle

Iron, Selenium, and Dementia; Epilepsy and Education; Brain Death Conversations

News and commentary from the world of neurology and neuroscience

MS Drugs Differ Most on Relapses, Not Disability, Real-World Study Shows

In new patients, disability score changes were similar over 2 years regardless of treatment

Autism Tied to 14-Year Gap in Life Expectancy

Large U.S. study points to preventable causes of excess mortality

Trial Confirms IVIG as Useful Therapy for Inflammatory Myopathy

But thromboembolic risks could be significant

First Therapy to Target Muscle Loss in Spinal Muscular Atrophy Gets FDA Approval

Motor function may improve with adjunctive apitegromab

Recommended News For You

Scream, It's Good for You; Release the Cancer Pigeons; Talk of Chemo Rationing

Patients With Early-Onset Cancer Unaware of Infertility Risk

Diagnosis of Mass Confined to the Kidney: Is It RCC or TCC?

mRNA-based COVID vaccines generate improved responses to immunotherapy

Marstacimab Gets FDA Nod for Hemophilia A or B Without Inhibitors

FDA Bans Red Dye No. 3 From Foods, Ingested Drugs

C/EBP? works in tandem with MYB to sustain AML cells' oncogenic program.

Recommended Articles For You

From Birthmarks to Tumors: The Science Behind Infantile Hemangioma  

A Revolutionary Guide to Calculating Absolute Neutrophil Counts 

Immune Surveillance Screening for Early Cancer Risk Detection 

Liquid Biopsies Unveiling the Future of Precision Cancer Management by 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer After Weight Loss; How Older Adults Use the Healthcare System.

2.

Mortality up for children with leukemia from lowest SES neighborhoods

3.

Response Duration After Stopping Enfortumab Vedotin in Bladder Cancer

4.

Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC

5.

Trial Supports Ivonescimab and Chemo for NSCLC Survival

1.

Emerging Therapies Through Personalized Tumor Ecosystem Remodeling

2.

Clinical Guidelines for Neutropenic Complication Monitoring

3.

Novel Antibody Conjugates in Cancer: Mechanisms, Clinical Evidence, and Therapeutic Implications

4.

Platelet Dysfunction During Severe Systemic Inflammation: Mechanisms, Clinical Implications, and Emerging Therapeutic Approaches

5.

What is Mullerian and How Does it Affect Your Health

1.

International Cancer Conference

2.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

1.

An In-Depth Look At The Signs And Symptoms Of Lymphoma

2.

Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals

3.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV

4.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

5.

CDK4/6 Inhibitors in Extending Overall Survival in HR+/HER2- aBC Patients in Clinical Trial and Real World

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot